News / Events 13.07.23

Maylim Supports Action Medical Research in Ziggurat 2023 Cycling Challenge

Ziggurat 2023 - Maylim - Action Medical Research

Maylim is proud to announce its participation in the Ziggurat 2023 Cycling Challenge, a charitable event supporting Action Medical Research. Following the success of last year’s ride, the Maylim team is once again gearing up for this exciting challenge.

The sixth edition of the annual cycling networking tour will witness approximately 70 riders embarking on a remarkable 4-day journey, commencing on 6th September. Travelling from London to the cobbled streets of Roubaix, this year’s route mirrors the path of the esteemed Paris-Roubaix race. As they pedal through picturesque countryside, the cyclists will pass by significant World Ward II landmarks and battlefields along the captivating French coast.

The Charity

Action Medical Research is an exceptional charity committed to improving the lives of children. In the UK alone, over 1,000 babies lose their lives each year due to premature birth, making it the leading course of death among children under five worldwide. By conducting ground-breaking medical research, Action Medical Research strives to combat the devasting impact of premature birth.

The Team

The Maylim team is not alone in this year’s challenge. Joining forces with colleagues from Multiplex, Tectonix, Flynn James and HTA Design, together they aim to raise an impressive sum of £20,000. No matter the size, every contribution will play a significant role in funding vital research to save the lives of prematurely born children.

Maylim and its dedicated team of riders express their gratitude for any support received and anticipate a successful ride that will contribute to Action Medical Research’s life-saving initiatives.

To contribute to the Ziggurat 2023 Cycling Challenge and help save the lives of children and babies born prematurely in the UK, please visit our donation page.

Our Sponsors

GOLD

Bourne Amenity


SILVER

MDN

Flynn James

Tectonix

BALI Chalk Fund